Public Employees Retirement System of Ohio Buys 598 Shares of Masimo Corporation $MASI

Public Employees Retirement System of Ohio raised its stake in shares of Masimo Corporation (NASDAQ:MASI) by 4.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 14,332 shares of the medical equipment provider’s stock after purchasing an additional 598 shares during the quarter. Public Employees Retirement System of Ohio’s holdings in Masimo were worth $2,411,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also bought and sold shares of the company. Twin Tree Management LP bought a new stake in Masimo during the first quarter valued at approximately $29,000. Farther Finance Advisors LLC lifted its position in Masimo by 128.9% during the first quarter. Farther Finance Advisors LLC now owns 206 shares of the medical equipment provider’s stock valued at $35,000 after purchasing an additional 116 shares during the last quarter. Anderson Financial Strategies LLC bought a new stake in Masimo during the first quarter valued at approximately $49,000. NBC Securities Inc. bought a new stake in Masimo during the first quarter valued at approximately $61,000. Finally, UMB Bank n.a. lifted its position in Masimo by 134.0% during the first quarter. UMB Bank n.a. now owns 447 shares of the medical equipment provider’s stock valued at $74,000 after purchasing an additional 256 shares during the last quarter. 85.96% of the stock is currently owned by institutional investors.

Insider Activity at Masimo

In related news, Director William R. Jellison bought 3,000 shares of the business’s stock in a transaction dated Monday, August 11th. The shares were purchased at an average price of $145.98 per share, with a total value of $437,940.00. Following the purchase, the director owned 4,790 shares of the company’s stock, valued at approximately $699,244.20. This trade represents a 167.60% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 9.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have commented on MASI shares. Zacks Research raised shares of Masimo from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, September 3rd. Piper Sandler lifted their price target on shares of Masimo from $200.00 to $210.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 6th. Wall Street Zen raised shares of Masimo from a “hold” rating to a “buy” rating in a research note on Sunday, September 28th. Finally, BTIG Research reissued a “buy” rating and set a $198.00 price target on shares of Masimo in a research note on Thursday, September 11th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $194.60.

Masimo Stock Up 2.5%

Shares of NASDAQ MASI opened at $146.05 on Friday. The company has a quick ratio of 1.61, a current ratio of 2.14 and a debt-to-equity ratio of 0.57. Masimo Corporation has a 52 week low of $131.60 and a 52 week high of $194.88. The firm’s fifty day moving average is $147.12 and its 200 day moving average is $156.14. The company has a market cap of $7.93 billion, a price-to-earnings ratio of -17.14 and a beta of 1.28.

Masimo (NASDAQ:MASI) last issued its earnings results on Tuesday, August 5th. The medical equipment provider reported $1.33 EPS for the quarter, topping the consensus estimate of $1.22 by $0.11. Masimo had a negative net margin of 24.85% and a positive return on equity of 26.54%. The company had revenue of $370.90 million for the quarter, compared to the consensus estimate of $368.65 million. During the same period in the previous year, the firm earned $0.86 earnings per share. The firm’s revenue for the quarter was up 7.7% on a year-over-year basis. On average, equities research analysts expect that Masimo Corporation will post 4.1 earnings per share for the current year.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.